PubRank

T A Ban

Author PubWeight™ 61.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The history of the psychopharmacology of schizophrenia. Can J Psychiatry 1997 2.64
2 Adynamic ileus during psychoactive medication: a report of three fatal and five severe cases. Can Med Assoc J 1967 1.40
3 Dose equivalent for haloperidol and phenothiazines. Can Med Assoc J 1967 1.38
4 Phenothiazines alone and in combination. Appl Ther 1966 1.14
5 Side effects and teratogenicity of lithium carbonate treatment. J Clin Pharmacol J New Drugs 1970 1.12
6 Toxic psychotic syndrome associated with chlorpromazine administration. Can Med Assoc J 1970 1.07
7 Chemical reduction of the compulsion to drink with metronidazole: a new treatment modality in the therapeutic program of the alcoholic. Curr Ther Res Clin Exp 1967 1.07
8 Neuroleptic-induced skin pigmentation in chronic hospitalized schizophrenic patients. Can J Psychiatry 1985 0.99
9 A clinical trial with nomifensin, a new antidepressant drug. Int J Clin Pharmacol Biopharm 1975 0.98
10 Clinical studies with propericiazine (R.P. 8909). Dis Nerv Syst 1967 0.96
11 A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression. Psychopharmacol Bull 1984 0.93
12 Metronidazole in the treatment of the alcoholic. Psychiatr Neurol (Basel) 1966 0.90
13 Interaction of indomethacin and ibuprofen with lithium in manic patients under a steady-state lithium level. J Clin Psychiatry 1980 0.90
14 DCR Budapest-Nashville in the diagnosis and classification of functional psychoses. Psychopathology 1988 0.90
15 A comparison of the hypnotic properties of mandrax and its two constituents. Curr Ther Res Clin Exp 1968 0.90
16 Clinical pharmacology of the tricyclic antidepressants. Appl Ther 1966 0.88
17 Description and distribution of the subtypes of chronic schizophrenia based on Leonhard's classification. Psychiatr Dev 1984 0.88
18 International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders. J Clin Psychopharmacol 1999 0.86
19 Flexible system criteria in chronic schizophrenia. Compr Psychiatry 1986 0.85
20 Viloxazine in the treatment of depressive neurosis: a controlled clinical study with doxepin and placebo. Br J Psychiatry 1980 0.84
21 Clobazam: uncontrolled and standard controlled clinical trials. Br J Clin Pharmacol 1979 0.84
22 The AMDP-system in chronic hospitalized schizophrenics. Compr Psychiatry 1985 0.84
23 The effect of hypnotics on rapid eye movement (REM). Int Z Klin Pharmakol Ther Toxikol 1968 0.84
24 Systematic clinical studies with trazodone: methodological aspects. Curr Ther Res Clin Exp 1973 0.83
25 Possible lack of anticholinergic effects with mianserin: a pilot study. J Clin Psychiatry 1980 0.83
26 The treatment of depressed geriatric patients. Am J Psychother 1978 0.83
27 Neurotoxicity with combined administration of lithium and a neuroleptic. Compr Psychiatry 1983 0.83
28 International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992-1997. Depress Anxiety 1999 0.82
29 Effect of withdrawal of antiparkinsonian medication on chronically hospitalized psychiatric patients. Laval Med 1970 0.82
30 Negative findings with nicotinic acid in the treatment of schizophrenias. Int Pharmacopsychiatry 1974 0.81
31 Nicotinic acid in the treatment of schizophrenias. Canadian Mental Health Association collaborative study: progress report II. Can Psychiatr Assoc J 1975 0.81
32 A double-blind placebo-controlled study to compare the autonomic effects of fluvoxamine with those of amitriptyline and doxepin in healthy volunteers. Br J Clin Pharmacol 1983 0.81
33 Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997. Eur Neuropsychopharmacol 1999 0.80
34 Propranolol in organic agitation. Lancet 1981 0.80
35 Systematic studies with amoxapine, a new antidepressant. Int Pharmacopsychiatry 1982 0.80
36 Sexual behavior of the male schizophrenic: the impact of illness and medications. Arch Sex Behav 1981 0.80
37 Orienting-reflex behavior and clinical psychopathology. Cond Reflex 1969 0.79
38 Research methodology and the pharmacotherapy of the chronic schizophrenias. Psychopharmacol Bull 1986 0.79
39 Organic problems in the aged: brain syndromes and alcoholism: psychiatric aspects of the organic brain syndrome and pharmacological approaches to treatment. J Geriatr Psychiatry 1978 0.79
40 Psychopharmacology and Leonhard's classification of chronic schizophrenias. Int Pharmacopsychiatry 1982 0.79
41 Rapid tranquilization: a comparative study of thiothixene and haloperidol. Prog Neuropsychopharmacol Biol Psychiatry 1984 0.78
42 Vitamins in psychiatry. Do they have a role? Drugs 1985 0.78
43 International study of expert judgement on therapeutic use of benzodiazepines and other psychotherapeutic medications: II. Pharmacotherapy of anxiety disorders. J Affect Disord 1995 0.78
44 Potentiation of therapeutic effects of nicotinic acid by pyridoxine in chronic schizophrenics. Can Psychiatr Assoc J 1973 0.78
45 Viloxazine in the treatment of endogenous depression. A standard (amitriptyline) controlled clinical study. Int Pharmacopsychiatry 1982 0.78
46 Pharmacotherapy of chronic hospitalized schizophrenics: prescription practices. Neuropsychobiology 1985 0.78
47 The place of doxepin among the anxiolytic-sedative drugs. Curr Ther Res Clin Exp 1972 0.78
48 Lack of indication for use of antiparkinson medication. A follow-up study. Dis Nerv Syst 1971 0.78
49 Psychotropic drug prescription pattern in a developing country (Nigeria). The need for an essential psychotherapeutic drug list. Int Pharmacopsychiatry 1982 0.78
50 An international survey of tardive dyskinesia. Prog Neuropsychopharmacol Biol Psychiatry 1985 0.78
51 Negative findings with megavitamins in schizophrenic patients: preliminary report. Commun Psychopharmacol 1977 0.78
52 Glycosaminoglycan polysulfate (Ateroid) in old-age dementias: effects upon depressive symptomatology in geriatric patients. Prog Neuropsychopharmacol Biol Psychiatry 1989 0.77
53 Neurotoxicity in patients with schizophrenia during lithium therapy. Compr Psychiatry 1982 0.77
54 Chronic schizophrenias: a guide to Leonhard's classification. Compr Psychiatry 1982 0.77
55 Nicotinic acid in the prevention and treatment of methionine-induced exacerbation of psychopathology in schizophrenics. Can Psychiatr Assoc J 1970 0.76
56 Electrocardiographic changes induced by phenothiazine drugs. Am Heart J 1965 0.76
57 A survey of extrapyramidal manifestations in the inpatient population of a psychiatric hospital. Laval Med 1970 0.76
58 Comparing facilities in a psychiatric unit of a general hospital and an admission unit of a psychiatric hospital. Can Psychiatr Assoc J 1973 0.76
59 International Study of Expert Judgement on Therapeutic Use of Benzodiazepines and Other Psychotherapeutic Medications: V. Treatment strategies in panic disorder, 1992-1997. J Clin Psychopharmacol 1998 0.76
60 Viloxazine: a review of the literature. Int Pharmacopsychiatry 1980 0.76
61 Comprehesiven clinical studies with thiothixene. Dis Nerv Syst 1975 0.76
62 Doxepin in the treatment of psychoneurotic patients. Curr Ther Res Clin Exp 1970 0.76
63 Thiothixene and the thioxanthenes. Adv Biochem Psychopharmacol 1974 0.76
64 Monoamine uptake inhibitors. Mod Probl Pharmacopsychiatry 1982 0.76
65 Amoxapine: a review of literature. Int Pharmacopsychiatry 1980 0.76
66 Transmethylation hypothesis of schizophrenia: methionine and nicotinic acid. Int Pharmacopsychiatry 1977 0.76
67 Pharmacotherapy of tension and anxiety. Curr Psychiatr Ther 1972 0.76
68 A comparative evaluation of doxepin and chlordiazepoxide in the treatment of psychoneurotic outpatients. Curr Ther Res Clin Exp 1970 0.76
69 The AMDP and NCDEU/BLIPS systems: similarities and differences. Mod Probl Pharmacopsychiatry 1983 0.75
70 Pimozide in the treatment of chronic schizophrenic patients. Curr Ther Res Clin Exp 1970 0.75
71 Non-equivalence of anti-psychotic drugs. Can Med Assoc J 1968 0.75
72 Transference, discrimination and reversal. A comparison between normals and pathological groups. Cond Reflex 1973 0.75
73 Nicotinic acid as adjuvant therapy in newly admitted schizophrenic patients. Can Med Assoc J 1970 0.75
74 Agranulocytosis associated with methotrimeprazine (Nozinan) administration: a report of three cases. Can Med Assoc J 1970 0.75
75 Studies with new drugs in the treatment of convulsive disorders. Int Z Klin Pharmakol Ther Toxikol 1968 0.75
76 Organizing and conducting clinical trials. Neuropsychobiology 1983 0.75
77 The benzodiazepines. II. Appl Ther 1967 0.75
78 Experimental geriatrics. Selection and prediction of therapeutic responsiveness in geriatric patients. Can Psychiatr Assoc J 1968 0.75
79 Drug interactions with psychoactive drugs. Dis Nerv Syst 1975 0.75
80 A comparative study with pipothiazine palmitate and fluphenazine enanthate in the treatment of schizophrenic patients. Curr Ther Res Clin Exp 1975 0.75
81 A placebo-controlled clinical study with trazodone in schizophrenic patients. Psychopharmacol Bull 1977 0.75
82 Nicotinic acid in the treatment of schizophrenias. Can Psychiatr Assoc J 1970 0.75
83 A standard- (trifluoperazine) controlled clinical study with clomacran in newly admitted schizophrenic patients. Psychopharmacol Bull 1977 0.75
84 Fluspirilene in the treatment of chronic schizophrenic patients. Curr Ther Res Clin Exp 1970 0.75
85 Desipramine plasma levels and therapeutic response. Psychopharmacol Bull 1978 0.75
86 Proceedings: Benzoctamine in the treatment of neurosis--an uncontrolled clinical study. Psychopharmacol Bull 1976 0.75
87 Conditioned reflex analysis of chronic schizophrenias. Can Psychiatr Assoc J 1972 0.75
88 Colloquium on clinical trials with antidepressants--behavioral, psychophysical, and pharmacokinetic measurements: Introduction. Psychopharmacol Bull 1978 0.75
89 Proceedings: Etafenoxin in the treatment of neurosis--an uncontrolled clinical study. Psychopharmacol Bull 1976 0.75
90 On-going national collaborative studies in Canada: niacin in the treatment of schizophrenias. Psychopharmacol Bull 1969 0.75
91 Chemotherapy in aged psychiaric patients. Can Psychiatr Assoc J 1969 0.75
92 Conditioning and the classification of the chronic schizophrenic patient. Pavlov J Biol Sci 1980 0.75
93 Nomifensin in the treatment of depression: a standard-controlled clinical study. Psychopharmacol Bull 1978 0.75
94 Haloperidol and the butyrophenones. Psychosomatics 1974 0.75
95 Differential effects of trazodone in depressed, schizophrenic and geriatric patients. Int J Clin Pharmacol 1974 0.75
96 International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: III. Clinical features affecting experts' therapeutic recommendations in anxiety disorders. Psychopharmacol Bull 1995 0.75
97 Nomifensin in the treatment of depression: a report on the Canadian part of a transcultural study. Psychopharmacol Bull 1978 0.75
98 Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--II. Report on a placebo-controlled clinical trial. Psychopharmacol Bull 1976 0.75
99 A survey of psychiatrists' practices related to the use of tricyclic antidepressants. Hosp Community Psychiatry 1986 0.75
100 Troxonium tosylate in drug-induced Parkinsonism: a controlled comparative study. J Clin Pharmacol New Drugs 1971 0.75
101 Clinical pharmacology of psychotropic drugs. Appl Ther 1967 0.75
102 [Introduction to the DCR system]. Psychiatr Pol 1989 0.75
103 A clinical study with propericiazine in chronic psychotic patients. Curr Ther Res Clin Exp 1971 0.75
104 Some recent biochemical findings with possible therapeutic implications for schizophrenia. J Clin Psychiatry 1978 0.75
105 [Preliminary report on the therapeutic action of flagyl in alcoholism]. Union Med Can 1966 0.75
106 Long-acting antipsychotic drugs. Psychopharmacol Bull 1980 0.75
107 An uncontrolled clinical trial with clomipramine in the treatment of depressed patients. Curr Ther Res Clin Exp 1973 0.75
108 An uncontrolled study with thiopropazate in the treatment of persistent dyskinesia. Psychopharmacol Bull 1977 0.75
109 Clomipramine (Anafranil) and behaviour therapy in obsessive-compulsive and phobic disorders. J Int Med Res 1977 0.75
110 Neuroleptic drugs and sexual function in schizophrenia. Mod Probl Pharmacopsychiatry 1980 0.75
111 A collaborative study of a new antidepressant, viloxazine, in neurotic and endogenous depressives. Int Pharmacopsychiatry 1982 0.75
112 Clinical pharmacology of the tricyclic antidepressants. II. Appl Ther 1967 0.75
113 An uncontrolled clinical study with EX 11-582A in the treatment of chronic schizophrenic patients. Psychopharmacol Bull 1977 0.75
114 A double-blind comparative clinical trial with maprotiline (Ludiomil) and imipramine in newly-admitted depressed patients. Curr Ther Res Clin Exp 1976 0.75
115 Treatment of depression with dexedrine and demerol. Curr Ther Res Clin Exp 1971 0.75
116 Drugs in geropsychiatry. Psychopharmacol Bull 1978 0.75
117 The effect of iminodibenzyls in the treatment of chronic psychotic patients. Curr Ther Res Clin Exp 1966 0.75
118 Haloperidol in the therapy of severe behavior disorders. Curr Psychiatr Ther 1976 0.75
119 Alcoholism and schizophrenia: diagnostic and therapeutic considerations. Alcohol Clin Exp Res 1977 0.75
120 Systematic studies with trimipramine--a new antidepressive drug. Can Psychiatr Assoc J 1967 0.75
121 An uncontrolled clinical trial carried out in Panama City, Panama. Psychopharmacol Bull 1976 0.75
122 Ascorbic acid levels in chronic psychotic patients. Psychopharmacol Commun 1975 0.75
123 CNS stimulants and anabolic substances in geropsychiatric therapy. Psychopharmacol Bull 1975 0.75
124 The place of thiothixene among the thioxanthenes. Curr Ther Res Clin Exp 1972 0.75
125 The use of methyldopa in schizophrenia: a review and comparative study. Am J Psychiatry 1972 0.75
126 A new comparative physiognomy of neuroleptics: a collaborative clinical report. Acta Psychiatr Belg 1972 0.75
127 Troxonium tosylate in the treatment of drug-induced extrapyramidal manifestations. Int Z Klin Pharmakol Ther Toxikol 1971 0.75
128 Trazodone in the treatment of neurosis--an uncontrolled clinical study. Psychopharmacol Bull 1976 0.75
129 Repeated-measures latin square designs in clinical pharmacology. Methods Find Exp Clin Pharmacol 1982 0.75
130 A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, I. Psychopharmacol Bull 1977 0.75
131 Mianserin: determination of therapeutic dose range. Int Pharmacopsychiatry 1980 0.75
132 An uncontrolled in clinical trial carried out in Verdun, Quebec, Canada. Psychopharmacol Bull 1976 0.75
133 An uncontrolled clinical study with piperacetazine in the maintenance treatment of chronic schizophrenic patients. Psychopharmacol Bull 1977 0.75
134 A transcultural study with clomacran: comparison of two assessment methods. Curr Ther Res Clin Exp 1974 0.75
135 Viloxazine in the treatment of depressive neurosis: a placebo and standard (imipramine) controlled clinical study. Int Pharmacopsychiatry 1980 0.75
136 Psychometric tests in evaluation of brain pathology, response to drugs. Geriatrics 1970 0.75
137 Clinical evaluation of a new psychotropic drug--molindone. Int Z Klin Pharmakol Ther Toxikol 1970 0.75
138 Bromperidol maintenance in schizophrenia. Pharmacopsychiatria 1982 0.75
139 Psychological tests: practice effect in geriatric patients. Geriatrics 1968 0.75
140 Effects of psychoactive agents on the conditioning of the microcirculation in the rat. Cond Reflex 1972 0.75
141 A review of nicotinic acid, N-methylated indoleamines and schizophrenia. Int Pharmacopsychiatry 1978 0.75
142 Test-retest performance in chronic schizophrenia on the Verdun Conditioning Program. Can Psychiatr Assoc J 1972 0.75
143 Glycosaminoglycan polysulfate in primary degenerative dementia. Pilot study of biologic and clinical effects. Neuropsychobiology 1995 0.75
144 Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--IV. A summary report. Psychopharmacol Bull 1976 0.75
145 Drug treatment in schizophrenia. Can Psychiatr Assoc J 1971 0.75
146 The effectiveness of combined phenothiazine and butyrophenone treatment in chronic schizophrenic patients. Curr Ther Res Clin Exp 1967 0.75
147 Mesoridazine in acute psychotic disturbances. Curr Ther Res Clin Exp 1967 0.75
148 Pharmacotherapy of chronic hospitalized schizophrenics: diagnosis and treatment. Psychiatr J Univ Ott 1984 0.75
149 Nicotinic acid in the treatment of schizophrenias. Practical and theoretical considerations. Neuropsychobiology 1975 0.75
150 Drug interactions in psychiatry. Int Pharmacopsychiatry 1978 0.75
151 Methodology and pitfalls in clinical testing of psychopharmacological drugs. Chemotherapy 1965 0.75
152 Clinical studies with clopenthixol (sordinol) on chronic psychiatric patients. Curr Ther Res Clin Exp 1966 0.75
153 Hydroxyzine, amitriptyline and their combination in the treatment of psychoneurotic patients. Curr Ther Res Clin Exp 1969 0.75
154 The prevalence of abnormal involuntary movements among chronic schizophrenics. Int Clin Psychopharmacol 1986 0.75
155 Proceedings: Introduction to the symposium on systematic studies with psychoactive drugs--new methods in the assessment of change. Psychopharmacol Bull 1976 0.75
156 Treatment of chronic schizophrenic patients with haloperidol and chlorpromazine combined. Curr Ther Res Clin Exp 1968 0.75
157 Conditioning in the prediction of therapeutic outcome in depressions. Cond Reflex 1969 0.75
158 Efficacy of haloperidol in drug refractory patients. Int J Neuropsychiatry 1967 0.75
159 A comparative study with benzodiazepines in chronic psychotic patients. Dis Nerv Syst 1966 0.75
160 A double-blind comparison of bromperidol and haloperidol in newly admitted schizophrenic patients. Pharmacopsychiatria 1981 0.75
161 Nicotinic acid, thioridazine, fluoxymesterone and their combinations in hospitalized geriatric patients: a systematic clinical study. Can Psychiatr Assoc J 1972 0.75
162 A comparative study of molindone and trifluoperazine. Curr Ther Res Clin Exp 1970 0.75
163 An introduction to systematic studies. Psychopharmacol Bull 1976 0.75
164 A comparison of clinically used psychoactive drugs in four Latin American countries and in Canada. (Argentina, Costa Rica, Mexico and Panama). Int J Clin Pharmacol 1974 0.75
165 Loxapine in psychogeriatrics: a placebo- and standard-controlled clinical investigation. J Clin Psychopharmacol 1982 0.75
166 Sex differences in long-term adverse effects of phenothiazines. Adv Biochem Psychopharmacol 1974 0.75
167 The effect of a protriptyline-perphenazine combination in chronic psychiatric patients. Curr Ther Res Clin Exp 1966 0.75
168 Some reflections on the methodology of clinical psychopharmacological research. Behav Neuropsychiatry 1971 0.75
169 Nicotinic acid and catechol-O-methyl-transferase activity in schizophrenia. Int J Clin Pharmacol 1973 0.75
170 A double-blind clinical trial of mianserin versus amitriptyline: differentiation by adverse symptomatology. Pharmacotherapy 1983 0.75
171 ECDEU (BPRS) and AMP (PAS) studies compared transculturally. Psychopharmacol Bull 1975 0.75
172 Pharmacotherapy of schizophrenia. Curr Psychiatr Ther 1976 0.75
173 Is maintenance neuroleptic therapy necessary in shallow hebephrenia. J Clin Psychiatry 1981 0.75
174 A standard-controlled clinical trial. Psychopharmacol Bull 1976 0.75
175 Protrptyline in the treatment of chronic schizophrenic patients. Curr Ther Res Clin Exp 1970 0.75
176 Psychopharmacology and psychosomatic disorders. Psychosomatics 1978 0.75
177 Neurotransmitters and receptors: clinical implications. Prog Neuropsychopharmacol Biol Psychiatry 1984 0.75
178 Clinical pharmacology of the phenothiazines. Appl Ther 1966 0.75
179 Treatment of acute and chronic psychoses with haloperidol: review of clinical results. Curr Ther Res Clin Exp 1969 0.75
180 A summary of systematic studies. Psychopharmacol Bull 1976 0.75
181 Amoxapine and viloxazine: review of the literature with special reference to clinical studies. Psychopharmacol Bull 1979 0.75
182 Doxepin in the treatment of psychoneurotic patients: a comparison between two clinical settings. Int Z Klin Pharmakol Ther Toxikol 1971 0.75
183 A preliminary investigation of WY-3263 versus amitriptyline in depressions. Curr Ther Res Clin Exp 1968 0.75
184 Prazepam in the treatment of psychoneurotic outpatients: a brief report. Curr Ther Res Clin Exp 1969 0.75
185 Clinical studies with MO-1255, a new monoamine oxidase inhibitor antidepressant. Curr Ther Res Clin Exp 1966 0.75
186 The use of nicotinic acid and pyridoxine in the treatment of schizophrenia. Int Pharmacopsychiatry 1981 0.75
187 Adynamic ileus during psychoactive medication. Can Med Assoc J 1967 0.75
188 CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients. Curr Ther Res Clin Exp 1970 0.75
189 A clinical-pharmacological study with EXP 561. Curr Ther Res Clin Exp 1967 0.75
190 Viloxazine in the treatment of depression: psychophysical measures and clinical response. Psychopharmacol Bull 1978 0.75
191 Uncontrolled study with pipothiazine palmitate. Int J Clin Pharmacol 1973 0.75
192 Prostaglandins and schizophrenia: a review. Prog Neuropsychopharmacol Biol Psychiatry 1982 0.75
193 Trimipramine in the treatment of depression: a comparison of single vs. divided dose administration. Psychopharmacol Bull 1978 0.75
194 Conditional reflex studies in the schizophrenias. Laval Med 1971 0.75
195 An adverse reaction unit: results and functions. Am J Psychiatry 1971 0.75
196 Pentylenetetrazol in the treatment of geriatric patients with disturbed memory function. J Clin Pharmacol New Drugs 1971 0.75
197 Nicotinic acid and psychiatry. Can Psychiatr Assoc J 1971 0.75
198 Adverse effects in maintenance therapy. Int Pharmacopsychiatry 1978 0.75
199 Affective disorders: biological aspects. Acta Neurol (Napoli) 1985 0.75
200 Pharmacotherapy of depression--a critical review. Psychosomatics 1975 0.75
201 Clinical psychopharmacology and psychiatry. Dis Nerv Syst 1975 0.75
202 Myths, theories and treatment of schizophrenia. Dis Nerv Syst 1977 0.75
203 Doxepin in the treatment of hospitalized and ambulatory psychoneurotic patients. Int J Clin Pharmacol 1972 0.75
204 Amoxapine in psychotic-delusional depression. Am J Psychiatry 1984 0.75
205 Combined administration of thioridazine and fluoxymesterone in the treatment of geriatric patients. Curr Ther Res Clin Exp 1970 0.75
206 Conditioning and learning in relation to disease. Act Nerv Super (Praha) 1985 0.75
207 Butaclamol in the treatment of schizophrenia. A standard-controlled clinical trial. Int Pharmacopsychiatry 1978 0.75
208 Doxepin in the treatment of psychoneurotic inpatients. Curr Ther Res Clin Exp 1971 0.75
209 Urinary incontinence associated with thioridazine administration. Can Med Assoc J 1971 0.75
210 Glycosaminoglycan polysulfate in old-age dementias: a factor-analytic study of change in psychopathologic symptoms. Neuropsychobiology 1988 0.75
211 R--806--03--01 in the treatment of depression: plasma levels and therapeutic response. Psychopharmacol Bull 1978 0.75
212 Propericiazine in psychiatric emergencies. A controlled comparative study. Can Psychiatr Assoc J 1972 0.75
213 Combined administration of thioridazine and nicotinic acid in the treatment of geriatric patients. Curr Ther Res Clin Exp 1971 0.75
214 Perspectives in biological psychiatry. Part 2: affective disorders. Psychosomatics 1977 0.75
215 Proceedings: Thyrotropin releasing hormone in depression: clinical and endocrinological findings. Psychopharmacol Bull 1976 0.75
216 Doxepin as adjuvant medication in the treatment of chronic schizophrenic patients: a comparative study. Curr Ther Res Clin Exp 1971 0.75
217 The effects of amoxapine and ethanol on psychomotor skills related to driving: a placebo and standard controlled study. Prog Neuropsychopharmacol 1981 0.75
218 Approaches to the management of the acutely psychotic patient. Psychiatr J Univ Ott 1984 0.75
219 The effect of psychostimulants on psychometric test performance with special reference to conflict avoidance behavior. Curr Ther Res Clin Exp 1970 0.75
220 A double-blind comparison of three dosages of flutroline (CP-36,584) in the treatment of schizophrenia. Int Pharmacopsychiatry 1980 0.75
221 Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study. Int Z Klin Pharmakol Ther Toxikol 1972 0.75
222 Senilex in the treatment of geriatric patients. Curr Ther Res Clin Exp 1971 0.75
223 Doxepin in the treatment of hospitalized and ambulatory psychoneurotic patients. Int Z Klin Pharmakol Ther Toxikol 1972 0.75
224 Pharmacological treatment of psychosomatic manifestations in geropsychiatric patients. Act Nerv Super (Praha) 1979 0.75
225 Uses and abuses of psychoactive drugs. South Med J 1978 0.75
226 Acute effects of viloxazine HCl and flurazepam when given alone and in combination on sleep EEG: a double-blind interaction study with normals. Pavlov J Biol Sci 1981 0.75
227 The place of thiothixene in the treatment of schizophrenic patients. A systematic clinical study. Can Psychiatr Assoc J 1970 0.75
228 Thiothixene. Its range of therapeutic activity. Int Z Klin Pharmakol Ther Toxikol 1970 0.75
229 The psychopharmacological treatment of depression in the medically ill patient. Can J Psychiatry 1984 0.75
230 A standard-controlled clinical study with benzquinamide in the treatment of chronic schizophrenic patients. Psychopharmacol Bull 1977 0.75
231 Psychopharmacology in the secondary and tertiary prevention of mental illness. Act Nerv Super (Praha) 1977 0.75
232 The nature and frequency fo the suicide syndrome, twenty years ago and today, in the english-speaking community of the province of Québec. Laval Med 1967 0.75
233 Conditional reflex studies in depression. Can Psychiatr Assoc J 1966 0.75
234 Psychopharmacological studies with neoserp and aldomet. Int J Neuropsychiatry 1965 0.75
235 Psychopathology, psychopharmacology and the organic brain syndromes. Part I. Psychosomatics 1976 0.75
236 Amoxapine: once versus divided daily doses in neurotic and endogenous depression. J Clin Psychiatry 1981 0.75
237 Effects of psychoactive drugs on conflict avoidance behavior in human subjects. Act Nerv Super (Praha) 1971 0.75
238 WIN 27,147-2 in the treatment of depression. An uncontrolled clinical study. Int Pharmacopsychiatry 1977 0.75
239 Psychopharmacology for the elderly. Prog Neuropsychopharmacol 1981 0.75
240 A standard-controlled clinical study with trazodone in schizophrenic patients. Psychopharmacol Bull 1977 0.75
241 [Specific responses to drug therapy and Leonhard classification of chronic schizophrenia]. Seishin Shinkeigaku Zasshi 1983 0.75
242 Trazodone in the treatment of schizophrenias. Curr Ther Res Clin Exp 1973 0.75
243 Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study. J Clin Psychiatry 1982 0.75
244 Fluphenazine enanthate in the treatment of chronic psychotic patients: a controlled clinical study. Int Z Klin Pharmakol Ther Toxikol 1971 0.75
245 [Propericiazine in the control of anti-social behavior]. Union Med Can 1966 0.75
246 Predictors of therapeutic responsivity to thiothixene in schizophrenics. Int Z Klin Pharmakol Ther Toxikol 1968 0.75
247 Geriatric psychopharmacology: clinical evaluation of brain function in the aged. Psychopharmacol Bull 1978 0.75
248 A clinical trial of thiothixene (Navane) in schizophrenics. Curr Ther Res Clin Exp 1967 0.75
249 Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--III. Standard-controlled clinical trial. Psychopharmacol Bull 1976 0.75
250 Diazepam in the treatment of insomnia in psychiatric patients. Curr Ther Res Clin Exp 1973 0.75
251 Leonhard's classification of the chronic schizophrenias. Can J Psychiatry 1984 0.75
252 Comprehensive clinical studies with trazodone. Curr Ther Res Clin Exp 1973 0.75
253 Proceedings: Trazodone: clinical and biochemical studies I. An uncontrolled clinical trial in depression. Psychopharmacol Bull 1976 0.75
254 Nicotinic acid in the treatment of chronic hospitalized schizophrenic patients: a placebo-controlled clinical study. Psychopharmacol Bull 1977 0.75
255 Trazodone in the treatment of organic brain syndromes, with special reference to psychogeriatrics. Curr Ther Res Clin Exp 1973 0.75
256 [A comparative study of propericiazine in the management of antisocial behavior]. Union Med Can 1967 0.75
257 Perspectives in biological psychiatry. Part 3: schizophrenia and organic brain syndrome. Psychosomatics 1977 0.75
258 Trazodone in the treatment of affective disorders. Curr Ther Res Clin Exp 1973 0.75
259 Pharmacotherapy of schizophrenia with special reference to megavitamin therapy. Can J Psychiatr Nurs 1973 0.75
260 A double-blind, comparative clinical trial with ludiomil (CIBA 34,276-Ba) and amitriptyline in newly admitted depressed patients. Curr Ther Res Clin Exp 1973 0.75
261 A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, II. Psychopharmacol Bull 1977 0.75
262 Introduction to the colloquium on new drugs in the treatment of schizophrenia. Psychopharmacol Bull 1977 0.75
263 A conditioning test battery for the study of psychopathological mechanisms and psychopharmacological effects. Can Psychiatr Assoc J 1970 0.75
264 TRH in depressive illness. Int Pharmacopsychiatry 1977 0.75
265 Clomacran in the treatment of schizophrenic patients: a comparison of two assessment methods. Int J Clin Pharmacol Biopharm 1975 0.75
266 Anxiety: measurement and methodology: Findings with a conditionning test battery: differential responsiveness to diazepam and doxepin [proceedings]. Psychopharmacol Bull 1977 0.75
267 A survey of extrapyramidal manifestations in patients attending an after care clinic of a psychiatric hospital. Laval Med 1970 0.75
268 An uncontrolled clinical study with clomacran in newly admitted schizophrenic patients. Psychopharmacol Bull 1977 0.75
269 Drug induced dementia. Prog Neuropsychopharmacol 1980 0.75
270 Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patients. Act Nerv Super (Praha) 1974 0.75
271 Proceedings: Butaclamol in the treatment of schizophrenia--a comparison of two treatment methods. Psychopharmacol Bull 1976 0.75
272 Neuroimaging and psychopharmacology in the diagnosis and treatment of dementia. Prog Neuropsychopharmacol Biol Psychiatry 1986 0.75
273 Who benefits from tricyclic antidepressants: a survey. J Clin Psychiatry 1988 0.75
274 [Pigmentation of the skin: rare side effect, following the prolonged administration of high doses of chlorpromazine]. Ann Dermatol Syphiligr (Paris) 1966 0.75
275 Combined administration of thioridazine, nicotinic acid, and fluoxymesterone in the treatment of geriatric patients. Curr Ther Res Clin Exp 1971 0.75
276 Psychopathology, psychopharmacology and the organic brain syndromes. Psychosomatics 1976 0.75
277 Distribution of Leonhard's subtypes of chronic schizophrenia in two cultures. Can J Psychiatry 1983 0.75
278 The neuroleptics. 8. Clinical methodology. Mod Probl Pharmacopsychiatry 1970 0.75
279 [Diagnosis of functional psychoses using the VRDC system. Preliminary report]. Psychiatr Pol 1989 0.75
280 Psychotherapeutic profile of a new psychoactive drug trazodone (AF-1161). Int Pharmacopsychiatry 1975 0.75
281 Tolbutamide jundice associated with multiple drug therapy. Can Med Assoc J 1970 0.75
282 Psychopharmacology of neuroses. Psychosomatics 1981 0.75
283 Multicenter clinical trials: methodological aspects. Mod Probl Pharmacopsychiatry 1981 0.75
284 Perspectives in biological psychiatry. Part I. Mental deficiency, personality disorders, and neuroses. Psychosomatics 1977 0.75
285 Doxepin and imipramine in the treatment of depression: a double-blind crossover clinical study with EKG recordings. Psychopharmacol Bull 1978 0.75
286 A standard-controlled clinical study with propericiazine in schizophrenic patients. Psychopharmacol Bull 1977 0.75
287 Comparative pharmacotherapy of the aging psychotic patient. Laval Med 1967 0.75